Drug Type Small molecule drug |
Synonyms AZ7608 |
Target |
Action inhibitors |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR positive non-small cell lung cancer | Preclinical | United Kingdom | 01 Jul 2019 | |
Non-Small Cell Lung Cancer | Preclinical | United States | - |